An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.

Tashkin, D P; Nathan, R A; Howland, W C; Minkwitz, M C; Simonson, S G; Bonuccelli, C M

Tashkin, D P; Nathan, R A; Howland, W C; Minkwitz, M C; Simonson, S G; Bonuccelli, C M.

Affiliation

Tashkin DP; University of California-Los Angeles, Department of Medicine 90095-1690, USA.

J Allergy Clin Immunol ; 103(2 Pt 1): 246-54, 1999 Feb.

Article in En | MEDLINE | ID: mdl-9949315

Subject(s)

Anti-Asthmatic Agents/therapeutic use; Asthma/drug therapy; Tosyl Compounds/therapeutic use; Adolescent; Adrenergic beta-Agonists/therapeutic use; Adult; Albuterol/therapeutic use; Analysis of Variance; Anti-Asthmatic Agents/adverse effects; Asthma/physiopathology; Bronchodilator Agents/therapeutic use; Child; Circadian Rhythm; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Indoles; Male; Phenylcarbamates; Sulfonamides; Tosyl Compounds/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Tosyl Compounds / Anti-Asthmatic Agents Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: J Allergy Clin Immunol Year: 1999 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links